← Back to Search

Text Reminders for COVID-19 Booster Uptake

N/A

Recruiting

Research Sponsored by University of California, Los Angeles

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients aged 18 or above

Last COVID-19 vaccine shot (including booster shot) occurred at least two months before the date when patient list are pulled in preparation for the trial, based on CAIR data. The last two criteria are meant to identify patients who are eligible for the bivalent booster.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 week after getting the text message

Awards & highlights

Study Summary

This trial tests if sending text reminders and messages can increase the uptake of COVID-19 booster vaccinations.

Who is the study for?

This trial is for adults who have completed their initial COVID-19 vaccine series, haven't had a booster in the last two months, and are registered with UCLA Health with an SMS-capable phone. It excludes those who've already scheduled or received a bivalent booster.Check my eligibility

What is being tested?

The study tests if text messages can increase uptake of the COVID-19 bivalent booster. Different message strategies include eligibility reminders, links to vaccination sites (narrow/broad options), and emphasizing doctors' recommendations and vaccine value.See study design

What are the potential side effects?

Since this trial focuses on communication methods rather than medical interventions, there are no direct side effects from participating. However, general side effects of COVID-19 vaccines may apply when individuals decide to get vaccinated.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

You are 18 years old or older.

Select...

Your last COVID-19 vaccine, including any booster shots, was given at least two months before the trial starts.

Select...

You have already received all the doses of a COVID-19 vaccine.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 week after getting the text message

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 week after getting the text message

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week after getting the text message for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Secondary Immunization

Secondary outcome measures

Link click rate in 1 week

booster take-up at UCLA/CVS in 2 weeks

booster take-up at UCLA/CVS in 4 weeks

Trial Design

6Treatment groups

Experimental Treatment

Active Control

Group I: Facilitate action narrowlyExperimental Treatment2 Interventions

Group II: Facilitate action broadlyExperimental Treatment2 Interventions

Group III: Boost intentions onlyExperimental Treatment2 Interventions

Group IV: Boost intentions and facilitate action narrowlyExperimental Treatment3 Interventions

Group V: Boost intentions and facilitate action broadlyExperimental Treatment3 Interventions

Group VI: HoldoutActive Control1 Intervention

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor

1,528 Previous Clinical Trials

10,136,851 Total Patients Enrolled

21 Trials studying COVID-19

733,604 Patients Enrolled for COVID-19

Media Library

Facilitate action narrowly Clinical Trial Eligibility Overview. Trial Name: NCT05586204 — N/A

COVID-19 Research Study Groups: Facilitate action narrowly, Boost intentions and facilitate action broadly, Boost intentions and facilitate action narrowly, Holdout, Facilitate action broadly, Boost intentions only

COVID-19 Clinical Trial 2023: Facilitate action narrowly Highlights & Side Effects. Trial Name: NCT05586204 — N/A

Facilitate action narrowly 2023 Treatment Timeline for Medical Study. Trial Name: NCT05586204 — N/A

COVID-19 Patient Testimony for trial: Trial Name: NCT05586204 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this medical study actively enrolling participants at the present moment?

"Clinicaltrials.gov verifies that this clinical trial, first published on 18th October 2022, is actively enrolling participants. The study has been revised most recently on 8th November 2022."

Answered by AI

What is the scope of patient involvement in this clinical trial?

"Affirmative. According to clinicaltrials.gov, the investigation posted on October 18th 2022 is actively searching for participants with 140000 individuals required from 1 site."

Answered by AI